Top

Reactions Weekly

Published in:

01-01-2023 | Multiple Sclerosis | Case report

Interferon-beta-1a

Immune thrombocytopenia: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Cisarovsky C, et al. Severe Late-Onset Drug-Induced Immune Thrombocytopenia Following IFN beta -1a Treatment: A Case Report of a 52-Year-Old Woman with Relapse-Remitting Multiple Sclerosis. Case Reports in Hematology 2022: 2022. Available from: URL: https://www.hindawi.com/journals/crihem/

Title: Interferon-beta-1a
Immune thrombocytopenia: case report
Publication date: 01-01-2023
Publisher: Springer International Publishing
Keywords: Multiple Sclerosis
Ocrelizumab
Thrombocytopenia
Tranexamic Acid
Interferon
Clonazepam
Ocrelizumab
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-30897-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Interferon-beta-1a

Immune thrombocytopenia: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Pembrolizumab

Dipyrone/piperacillin/tazobactam

Ipilimumab/nivolumab/pembrolizumab

Lanreotide

Nivolumab